Bone tissue homeostasis is governed by hormones, growth factors, and cytokines and can be distorted by environmental pollutants, such as ligands to the aryl hydrocarbon receptor (AhR). A transgenic mouse expressing a constitutively active aryl hydrocarbon receptor (CA-AhR), mimicking continuous low-dose exposure to AhR ligands, was used to explore potential long-term effects of these ligands on bone. The density, content, and dimensions of cortical and trabecular bone, as well as physical properties, were significantly altered in female transgenic mice, while almost no alterations were detected in males. Osteoclast volume density and serum level of C-telopeptide of type I collagen (CTX), reflecting osteoclast activity, were both increased by~60% in female CA-AhR mice, while serum tartrate-resistant acid phosphatase (TRAP) 5b, reflecting osteoclast numbers, was unchanged. Subsequently, the resorption index (CTX/TRAP 5b) was increased by 90%, indicating increased osteoclast activity in female CA-AhR. Moreover, the protein level of the osteoclast collagenase cathepsin K was increased by 40% in bone extracts of female CA-AhR mice. The messenger RNA expression of several osteoclast-and osteoblast-associated genes was altered in female transgenic mice but not in males. Notably, early markers for osteoclast and osteoblast differentiation were normal, while the expression of functional markers of osteoclasts and osteoblasts were reduced. In conclusion, a low continuous activation of the AhR leads to a skeletal phenotype with increased bone resorption associated with more ductile bones in females but not in males. The results indicate the presence of an interaction between the AhR and a femalespecific mechanism implicated in inhibition of osteoclast development and function. Female bone tissue appears more susceptible to dioxins and other AhR ligands than male bone tissue.
Dioxins are persistent environmental pollutants with endocrine disrupting properties and cause immunosuppression, cancer, as well as developmental and reproductive defects , 2001 WHO-ECEH/IPCS, 2000) . Dioxins are lipophilic compounds that are very resistant to degradation and the half-life of the most potent congener, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), is estimated to be more than 7 years in humans , 2001 . As a consequence, these compounds are bioaccumulated in tissues and biomagnified in the food chain. Health risk assessments show that the safety margin for human exposure to dioxins is minimal or nonexisting , 2001 .
Most, if not all, effects of dioxins are mediated by the aryl hydrocarbon receptor (AhR), which belongs to a superfamily of transcription factors called basic helix-loop-helix/Per-Arnt-Sim (bHLH-PAS) domain proteins. This class of transcription factors responds to a variety of environmental stimuli, such as hypoxia, circadian rythmicity, and xenobiotica (Carlson and Perdew, 2002; Gu et al., 2000) . One frequently used marker for AhR activity is cytochrome P450 1A1 (CYP1A1) and the most potent activator of the receptor is TCDD.
Both osteoblasts and osteoclasts have been shown to express the AhR (Ilvesaro et al., 2005) , but the long-term effects of lowdose exposure to dioxins or other AhR ligands on bone tissue have not previously been studied. However, acute and shortterm exposure in vivo experiments have shown that dioxins and dioxin-like compounds cause profound effects in bone tissue, including geometrical changes, decreased bone strength, and decreased bone mineral density (BMD) (Hermsen et al., 2008; Jämsa et al., 2001; Lind et al., 1999 Lind et al., , 2000 Lind et al., , 2009 Miettinen et al., 2005; Nishimura et al., 2009) . The messenger RNA (mRNA) levels of collagen type I, alkaline phosphatase (ALP), and osteocalcin were reduced in tibia of male mice exposed to TCDD via lactation (Nishimura et al., 2009) . In vitro experiments have shown that AhR ligands directly affect bone cells. Studies on osteoblasts have shown that the differentiation of osteoblasts is inhibited when the cells are exposed to AhR ligands (Gierthy et al., 1994; Korkalainen et al., 2009; Naruse et al., 2002; Ryan et al., 2007; Singh et al., 2000) . The gene expression in osteoblastic cells has also been reported to be affected by TCDD. The expression of osteopontin decreased more rapidly and at lower concentration of TCDD compared to CYP1A1 induction in osteosarcoma cells (Wejheden et al., 2006) . The mRNA expression and the protein level of IGFBP-6, a potent mitogen for osteoblasts, were increased in osteoblastic osteosarcoma cells exposed to TCDD in combination with estrogen, while estrogen alone exerted an inhibitory effect (Guo et al., 2007) . Another study showed that dioxin displayed effects on the secretion of collagenase-3 in osteosarcoma cells (Partridge et al., 2000) . Osteoclast formation has been shown to be inhibited by the AhR ligands 3-methylcholantrene (3-MC) (Naruse et al., 2004) , benzo [a] pyrene (BaP) (Voronov et al., 2005 (Voronov et al., , 2008 , and TCDD at a concentration of only 100 fM (Korkalainen et al., 2009) . However, the resorptive activity of mature osteoclasts was not disturbed by short-term exposure to TCDD (Ilvesaro et al., 2005) .
In the present study, we have examined the bone phenotype of a transgenic mouse with a constitutively active aryl hydrocarbon receptor (CA-AhR), which has an early onset during embryonic development. Consequently, the mimicked exposure is activated in utero and continues throughout life. The induction of CYP1A1 in livers from these transgenic mice is comparable to the induction of CYP1A1 in wild-type (WT) mice exposed to a single dose of 0.3 lg TCDD/kg body weight, reflecting a rather low activity of the transgenic receptor . The transgenic mouse displays typical dioxin-related effects, such as liver enlargement and thymus atrophy Brunnberg et al., 2006) . This mouse can thus be used as a model system for the human exposure situation since humans are exposed to low doses of AhR ligands from the first day of conception throughout life. The aim of this study was to characterize the bone phenotype of transgenic CAAhR mice and explore possible gender-related differences.
MATERIALS AND METHODS
Animals. All animal procedures complied with the national guidelines in Sweden, and the experimental procedures were reviewed and approved by the Northern Stockholm Regional Board for Animal Welfare.
Transgenic mice with a CA-AhR were backcrossed into C57BL/6 background for more than 10 generations, resulting in a congenic background of C57BL/6. The construct of the truncated receptor was subcloned into pElSR containing the mouse IgH enhancer (El), a modified simian virus 40 promoter (SRa), and a polyadenylation site (Bodrug et al., 1994) . The construct encoding the transgenic receptor (CA-AhR) lacks the amino acids 288-421 in the ligand-binding domain and results in a constitutively active receptor (McGuire et al., 2001) . The transgenic receptor is expressed in all organs examined so far, e.g., liver, stomach, thymus, spleen, kidney, and bone marrow (Andersson et al., , 2003 . C57BL/6N served as WT controls. Mice were housed in ventilated filter-top cages in the local animal facility. Animals were fed conventional rodent chow and tap water ad libitum and exposed to 12-h light and 12-h dark cycles. WT and CA-AhR male and female mice were sacrificed by CO 2 asphyxiation, followed by cervical dislocation at 3 months of age. This age was selected to ensure sexual maturity of the mice. Blood was immediately collected by heart puncture and serum was prepared according to standard methods. Briefly, the blood was kept in room temperature for 1 h and then placed on ice. The samples were centrifuged at 3000 RPM ¼ 530 3 g for 10 min at þ 4°C. Serum was collected and stored at À20°C until further analysis. Body weights were measured and long bones excised and prepared. Tibiae for the peripheral quantitative computed tomography (pQCT) analysis and the three-point bending test were put in Ringer's solution (2.5mM Tris, 1.9mM CaCl 2 (H 2 O), 5.4mM KCl, and 2.1mM HCl; pH 7.4) and stored at À20°C until analysis. Tibiae for immunohistochemistry were fixed in phosphate buffered 4% paraformaldehyde for 2 days, in PBS for 2 days, and then decalcified in 20% formic acid for 2 days and paraffin embedded. Femurs and humeri for RNA isolation and protein extraction were put in liquid nitrogen and stored at À80°C.
Peripheral quantitative computed tomography. Tibiae were analyzed with pQCT (Stratec XCT Research SAþ with software version 5.50R; Norland Stratec Medizintechnik GmbH, Birkenfeld, Germany). Precision, long-term stability, linearity, and accuracy of the pQCT bone scanner were evaluated every third day using a validation phantom. To estimate the reproducibility of the pQCT measurements, the coefficient of variation was calculated from 10 repeated measurements with a single sample being repositioned before each measurement. Cortical parameters were determined by middiaphyseal scans at a point located 50% of the total bone length. The threshold value was set to 710 mg/cm 3 ; values above that were defined as cortical bone. Trabecular parameters were determined by metaphyseal scans at a point located 5.7% of the total bone length from the proximal end. Values ranging from 280 to 400 mg/cm 3 were considered to be trabecular bone. The voxel size was set to 0.07 mm. The number of mice analyzed for pQCT was as follows: females: WT, n ¼ 9, and CA-AhR, n ¼ 8, and males: WT, n ¼ 12, and CA-AhR, n ¼ 12.
Biomechanical testing. Three-point bending was applied with an electromechanical material testing machine (Avalon Technology Inc., Rochester, MN) with a span length of 8 mm and a loading speed of about 0.5 mm/s. The load was applied at the middiaphysis in an anterioposterior direction at the same point as the pQCT measurement for cortical bone was performed. Three-point bending was performed on the same specimens that were analyzed with pQCT. Load and displacement were recorded with 50 Hz (Testware II) during the deformation. Based on the load and displacement data, the load at failure (Newton), displacement at failure (millimeter), energy absorption until failure (area under the curve, Newton 3 millimeter), stiffness to failure (slope of the load-deflection curve to failure, Newton per millimeter), and maximal stiffness (Newton per millimeter) were calculated. The number of mice analyzed for biomechanical testing was as follows: females: WT, n ¼ 6, and CA-AhR, n ¼ 8, and males: WT, n ¼ 11, and CA-AhR, n ¼ 11.
Serum analysis of C-telopeptide of type I collagen, N-terminal propeptide of type I procollagen, and tartrate-resistant acid phosphatase 5b. The serum level of C-telopeptide of type I collagen (CTX) was analyzed with a RatLaps ELISA (Immunodiagnostic Systems Nordic a/s, Herlev, Denmark) according to the manufacturer's protocol. Quantification of the N-terminal propeptide of type I procollagen (PINP) was performed with a PINP EIA kit (Immunodiagnostic Systems Nordic a/s) according to manufacturer's protocol. Tartrate-resistant acid phosphatase (TRAP) exists in two forms, the monomeric TRAP 5a and the proteolytically processed TRAP 5b. Serum TRAP 5b reflects the total number of osteoclasts rather than their activity (Alatalo et al., 2000 (Alatalo et al., , 2003 (Alatalo et al., , 2004 Chu et al., 2003) . The serum level of TRAP 5b was analyzed with Mouse TRAP Assay (Immunodiagnostic Systems Nordic a/s) according to the manufacturer's protocol. All serum analyses were performed on serum from female mice: WT, n ¼ 8, and CA-AhR, n ¼ 10, and on male mice: WT, n ¼ 8, and CA-AhR, n ¼ 7.
Immunohistochemistry. Sections with a thickness of 5 lm were transferred to glass slides (SuperFrost, Menzel-Gläser, Germany) and deparaffinized and rehydrated. To block endogenous peroxidase activity, the sections were treated with 3% H 2 O 2 and nonspecific staining was prevented by treatment with 5% normal horse serum. Immunostaining for cathepsin K was performed with a polyclonal rabbit antibody at a dilution of 1:1000. Antiserum toward TRANSGENIC MICE WITH CA-AHR DISPLAY A GENDER-SPECIFIC BONE PHENOTYPE 49 cathepsin K was produced in rabbits using a synthetic peptide derived from the mouse cathepsin K sequence (NH 2 -þ318 CGITNMASFPKM þ329 -COOH) (Yamaza et al., 1998) as the immunogen. The peptide was conjugated to keyhole limpet hemocyanin via the N-terminal cysteine and maleimide as crosslinker (Innovagen AB, Sweden). Two rabbits were immunized with 200 lg each of the peptide conjugate and Freund's complete adjuvant week 1. Booster injections with Freund's incomplete adjuvant were administered week 2 (200 lg peptide conjugate) and weeks 3 and 7 (100 lg peptide conjugate). Serum was collected (Agrisera, Vännäs, Sweden). The specificity of the antiserum has been established in a previous study with a cathepsin K knockout mouse (Zenger et al., 2007) . Secondary antibody was biotinylated horse antimouse/rabbit IgG (Vector Laboratories, Inc., CA).
Stereological analysis of osteoclast volume. Sections immunohistochemically stained for cathepsin K were used to quantify the osteoclast volume density. The relative volume densities of osteoclasts (Oc.V) in the metaphyseal bone were estimated as the ratio of area occupied by osteoclasts to the corresponding reference area, tissue volume (TV) or bone volume (BV) and referred to as Oc.V/TV and Oc.V/BV. Measurements were performed on printed copies (1 pixel ¼ 0.42 lm) by point counting using a square lattice (1.0 cm for osteoclast and 2.0 cm for reference area measurements) (Hollberg et al., 2002) . Osteoclasts were defined as cathepsin K-positive cells lining the trabecular surface. The area below the growth zone was quantified. The numbers of mice counted for stereological analysis were as follows: females: WT, n ¼ 5, and CA-AhR, n ¼ 4 and males: WT, n ¼ 5, and CA-AhR, n ¼ 4. Two histological sections were analyzed for each mouse.
Western blot and protein quantification. Humeri were cut into small pieces, placed in homogenization solution (0.15M KCl, 0.1% Triton X-100, and Complete protease inhibitor cocktail tablets [Roche, Germany]), and homogenized with a Polytron homogenizer. The homogenates were cleared by centrifugation for 20 min at 13,000 RPM ¼ 9940 3 g at 4°C and the supernatant was collected and stored at À20°C. Protein concentration was determined with Micro BCA Protein Assay Kit (Pierce, IL) and 5 lg of protein was subjected to 10% SDS-polyacrylamide gel electrophoresis under reducing conditions and electroblotted to immuno-polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA). Blocking was performed with 1% bovine serum albumin in tris buffered saline tween-20 (0.05% Tween 20 in tris buffered saline [20mM Tris, pH 7.5, and 500mM NaCl]). The membranes were then incubated with primary antibodies against glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (ab9485; Abcam, Cambridge, UK) diluted 1:2500 and cathepsin K (described above) diluted 1:1000. The membranes were washed and incubated with a secondary antibody, anti-rabbit IgG conjugated with peroxidase (Calbiochem; EMD Chemicals Inc., Darmstadt, Germany) at a dilution of 1:5000. The membranes were developed with Western Lightning Plus-ECL (PerkinElmer Inc., MA) according to the manufacturer's protocol, and the chemiluminescence was measured (FluorChem SP; Alpha Innotech, San Leandro, CA). GAPDH was used as an endogenous control. The absolute intensity of the bands was calculated, and the relative intensity of cathepsin K was calculated by dividing the absolute intensity of the protein with the absolute intensity of the endogenous control (GAPDH). The image analysis was performed with the Adobe Photoshop CS2 software. The data represent three animals in each group.
TRAP activity. The activity of TRAP in protein isolates from humerus was assayed in 96-well plates using p-nitrophenylphosphate (pNPP) as a substrate in the incubation medium, pH 5.8, with final concentrations as follows: 10mM pNPP, 0.1M NaAc, 0.15M KCl, 0.1% (vol/vol) Triton X-100, 10mM disodium tartrate, 1mM ascorbic acid, 100lM Fe(NH 4 ) 2 (SO 4 ) 2 , and ±100lM of the TRAP inhibitor sodium molybdate. After 40-min incubation at 37°C, the reaction was stopped by the addition of 50 ll 0.9M NaOH and the liberated p-nitrophenol was converted to p-nitrophenolate. The absorbance was measured at 405 nm in a Spectramax 250 spectrophotometer (Molecular Devices, Sunnyvale, CA). One unit of TRAP activity corresponds to 1 lmol of p-nitrophenol liberated per minute at 37°C. True TRAP activity was calculated as the difference between wells with and without sodium molybdate. The TRAP activity was normalized against the protein concentration to obtain units per milligram protein. Each sample was analyzed in duplicates, and the groups consisted of 8 WT females, 10 CA-AhR females, 8 WT males, and 7 CA-AhR males.
ALP activity. The enzymatic activity of ALP was measured in protein extracts from humerus. Five microliters of protein isolate was incubated in a total volume of 300 ll substrate solution (0.1M diethanolamine, 1.0mM MgCl 2 , and10mM, pNPP, pH 9.8) in 96-well plates. The plates were incubated for 2.5 min at 37°C, and the absorbance was read at 405 nm. Each sample was analyzed in duplicates. A standard curve with known concentrations of pNP (0, 0.01, 0.05, 0.1, and 0.2 lmol/ml) was included on the plate in order to calculate units per milliliter (1 U corresponds to 1 lmol pNP/min). The results were normalized against the protein concentration to yield units per milligram protein.
RNA purification, quantitative real-time PCR, and PCR. Femurs from WT and transgenic mice were homogenized in QIAzol Lysis Reagent (QIAGEN, Hilden, Germany) with a Polytron homogenizer. RNA was extracted with RNeasy Lipid Tissue Mini Kit (QIAGEN) according to the manufacturer's protocol, where the optional DNase digestion step was included. Complementary DNA (cDNA) synthesis was performed with Omniscript (QIAGEN) according to the manufacturer's protocol.
Quantitative real-time PCR (qPCR) was performed using Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen, Carlsbad, CA) and an iCycler iQ (Bio-Rad). The individual amplification reactions contained 13 Platinum SYBR Green mix, 3.5mM MgCl 2 , 10nM Fluorescein Calibration Dye (Bio-Rad), 17 ng cDNA, and the appropriate concentration of primers listed in Table 1 . Analysis of CYP1A1 gene expression was performed with TaqMan Gene Expression assays (assay ID: Mm00487218_m1; Applied Biosystems, Foster City, CA). In the CYP1A1 reaction, 100 ng cDNA was used and the annealing temperature was 60°C. The thermocycling program was 95°C for 3 min for polymerase activation, followed by 40 cycles of 30 s at 95°C and 30 s of annealing temperature according to Table 1 . Ct values were derived from qPCR graphs, and the fold change was calculated according to the comparative Ct method (2 ÀDDCt ) in which GAPDH was used as reference gene. The expression of GAPDH did not differ between the WT and the transgenic mice (data not shown). Melting-curve analysis was performed for each primer pair to verify the specificity of the primers and to confirm that primer-dimers were not formed in the reaction. Each sample was analyzed in triplicates.
PCR was performed with GeneAmp PCR System 9700 (Applied Biosystems), and the primer sequences for the transgenic receptor (CA-AhR) were as follows: 5#-GGAGTGCCTCGAGGGCAAGCCGAGTTCAGCAAA-3# and 5#-CCATCGCTCGAGCAATGAATTTCCAAGGGA-3# generating a fragment of 726 bp. The individual amplification reactions contained 13 Platinum SYBR Green mix, 3.5mM MgCl 2 , 10nM Fluorescein Calibration Dye (Bio-Rad), 100 ng cDNA, and 900nM of each primer. The PCR program was 95°C for 2 min, followed by 40 cycles of 30 s of 95°C, 30 s of 55°C, and 30 s of 72°C followed by 7 min of 72°C. Primers and annealing temperature used in the GAPDH reaction are listed in Table 1 . The PCR products were separated by electrophoresis on a 1% agarose gel containing ethidium bromide and visualized and photographed under ultraviolet light.
Statistical analysis. The pQCT and biomechanical data were adjusted for body weight and evaluated by analysis of covariance. Serum analyses, qPCR, Western blot, TRAP activity, and ALP activity assays were evaluated with Student's t-test. Data are presented as means ± SD of the individuals in the groups of WT and transgenic CA-AhR mice. p Values < 0.05 were considered to be statistically significant and are represented by *, p values < 0.01 are represented by **, and p values < 0.001 are represented by ***.
RESULTS
The body weights did not significantly differ between WT and the transgenic (CA-AhR) mice (females: WT 20.7 ± 1.03 g 50 WEJHEDEN ET AL.
and CA-AhR 20.3 ± 1.06 g and males: WT 27.7 ± 2.2 g and CA-AhR 26.4 ± 2.3 g). The length of tibia was unchanged (females: WT 16.7 ± 0.2 mm and CA-AhR 16.5 ± 0.2 mm and males: WT 17.0 ± 0.2 mm and CA-AhR 16.9 ± 0.3 mm).
Bone Phenotype
The bone phenotype of transgenic mice with a CA-AhR was significantly altered when compared to WT mice, especially in female CA-AhR mice. pQCT analysis of the metaphyseal part of tibia demonstrated that the trabecular area and the trabecular bone mineral content (BMC) were increased by 16 and 22%, respectively, in female CA-AhR mice (Table 2) . However, the trabecular BMD was not changed. In male transgenic mice, the trabecular BMD was increased by 12% but no other parameters were different.
In the middiaphysis of female transgenic mice, the crosssectional area (CSA) was increased by 4%, the endosteal circumference was also increased by 4%, and the periosteal circumference was increased by 2%, reflecting slightly wider bones when compared to WT (Table 3) . However, the cortical thickness was normal compared to WT mice. Volumetric cortical BMD and total BMD were decreased by 2 and 3%, respectively, demonstrating a generally decreased BMD in the diaphysis of female transgenic mice. In males, no changes were detected in the cortical part of the bone (Table 3) . To assess whether these changes affected the physical strength of the bones, a three-point bending test was performed. The results showed that the displacement was increased by 14%, while the stiffness and the maximal stiffness were decreased by 15 and 22%, respectively, in female transgenic mice (Table 4) . Thus, the bones of female transgenic mice were more ductile compared to WT mice. No changes in biomechanical properties of the bones from male transgenic mice were detected (Table 4) .
Analysis of Bone Markers in Serum
Serum analyses of several bone markers were performed in order to study if bone formation, bone resorption, or both were affected by an activated AhR. Analysis of the bone resorption marker CTX demonstrated that total osteoclast resorptive activity was elevated by 63% in females but not in males (Fig. 1A) . However, TRAP 5b, a marker reflecting the total number of osteoclasts in the entire skeleton rather than their activity (Alatalo et al., 2000 (Alatalo et al., , 2003 (Alatalo et al., , 2004 Chu et al., 2003) , was unchanged (Fig. 1B) . The resorption index, CTX/ TRAP 5b, which indicates the mean osteoclast activity (Rissanen et al., 2008) , was significantly increased by 91% in the transgenic females (Fig. 1C) . No alterations were seen in male transgenic mice. The bone formation marker PINP was elevated by 30% in serum from female CA-AhR mice ( Fig. 2A) , whereas another osteoblast marker, ALP, was decreased by 27% in bone extracts from female transgenic mice (Fig. 2B) . No changes were detected in male transgenic mice.
Expression and Activity of the CA-AhR
PCR was performed to verify that the transgenic receptor was present in bone tissue of the transgenic mice. As shown in Figure 3 , no fragment was detected in the WT animals, while the receptor was clearly detectable in the transgenic mice. The minor individual difference in CA-AhR expression among the transgenic mice is likely due to biological variation and does not seem to affect the transcriptional activity of the receptor. The marker gene for AhR activity, CYP1A1, was hardly detectable in WT mice of either gender (female WT Ct value > 35 and male WT Ct value > 36) but readily detected and equally expressed in both genders of the transgenic mice (female CA-AhR Ct value 29.1 ± 1.3 and male CA-AhR Ct value 29.1 ± 1.3). Thus, both the expression of the transgenic receptor and its transcriptional activity (i.e., induction of CYP1A1) were equal in bone tissue of either gender. 
Load at failure (N) 11.7 ± 0.9 11.5 ± 1.1 15.7 ± 1.4 15.2 ± 2.8 Displacement (mm) 0.72 ± 0.06 0.83 ± 0.08* 0.7 ± 0.2 0.7 ± 0.1 Energy to failure (J) 5.1 ± 0.6 5.0 ± 0.7 6.1 ± 1.8 6.5 ± 1.9 Stiffness (N/mm) 16.5 ± 1.7 14.0 ± 1.5* 23.1 ± 4.2 22.2 ± 5.2 Maximal stiffness (N/mm) 23.0 ± 3.4 18.0 ± 3.1* 28.6 ± 6.7 29.1 ± 6.3
Note. Values are given as mean ± SD. *p < 0.05.
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Gene Expression
Gene expression analysis was performed on several markers for osteoblast and osteoclast differentiation and function in order to study which genes might be involved in the disturbed bone phenotype of female transgenic mice. The expression levels of several genes associated with osteoclasts and osteoblasts were decreased in female CA-AhR mice but unaffected in males. Notably, early differentiation markers of osteoclastogenesis such as RANK, NFATc1, and OSCAR were not altered, suggesting that the early steps in the differentiation of osteoclasts were normal (Table 5) . Also, the ratio between the osteoblast produced RANKL and OPG (RANKL/OPG) was 1.8-fold higher in female CA-AhR mice, suggesting an increased drive for osteoclast formation ( Table 5 ). Markers that are involved in the resorptive action of the osteoclasts, such as TRAP, cathepsin K, and MMP-9, were decreased twofold to fivefold in female CA-AhR mice (Table 5) . A similar pattern FIG. 1. Serum levels of CTX (A) and TRAP 5b (B) in transgenic mice with a CA-AhR. The ratio between the serum levels of CTX and TRAP 5b indicates the mean osteoclast activity and gives the resorption index (C). Values are given in mean ± SD. ***p < 0.001. Females: WT, n ¼ 8, and CA-AhR, n ¼ 10, and males: WT, n ¼ 8, and CA-AhR, n ¼ 7.
FIG. 2.
Bone formation markers. PINP was measured in serum (A), while enzyme activity of ALP was measured in protein isolate from humerus (B). Values are given in mean ± SD. **p < 0.01 and ***p < 0.001. Females: WT, n ¼ 8, and CA-AhR, n ¼ 10, and males: WT, n ¼ 8, and CA-AhR, n ¼ 7.
TRANSGENIC MICE WITH CA-AHR DISPLAY A GENDER-SPECIFIC BONE PHENOTYPE 53 was seen with the osteoblast-associated genes (Table 5 ). All the early differentiation markers, except Runx2, were unchanged, while functional markers, such as osteocalcin and collagen, were expressed approximately twofold less in female CA-AhR mice. Also, the expression of DMP-1, which predominantly is produced by the osteocytes, was reduced 3.7-fold in female CA-AhR mice. No change in the expression pattern was detected in male transgenic mice (Table 5 ).
Protein Levels
Cathepsin K is the major enzyme participating in osteoclastmediated collagen degradation of the bone matrix. According to serum analysis of CTX, there was an increased degradation of collagen type I in female transgenic mice. As expected, Western blot analysis displayed that the level of the 28-30 kDa active form of cathepsin K protein was increased by 40% in humeri of female transgenic mice but unchanged in male transgenic mice (Fig. 4A) .
TRAP has long been used as a histochemical marker for osteoclasts and is suggested to be involved in the resorption process as well as in osteoclast adhesion and migration. TRAP is secreted as an inactive monomeric form that is cleaved by proteases (e.g., cathepsin K) to generate the active form of the enzyme. Although the protein level of cathepsin K was increased in female CA-AhR mice, the activity of TRAP was decreased by 42% in bone extracts from humerus (Fig. 4B) . The TRAP activity was also decreased in male CA-AhR mice, albeit not to the same extent as in the females .   FIG. 3 . The expression of the modified receptor (CA-AhR) was analyzed with PCR. Neither the WT females nor the WT males expressed the CA-AhR, whereas the mutated receptor was detected in both genders of the transgenic mice. GAPDH was used as loading control. Five mice per group were analyzed.
TABLE 5 Quantification of the mRNA Expression
Females
Males
Note. The fold change values are presented as mean ± SD. *p < 0.05 and **p < 0.01.
FIG. 4.
Protein expression of cathepsin K (A) was quantified by the relative optical intensity of the bands on the membrane from Western blot. The intensity of the bands for cathepsin K (28 kDa) was normalized against the intensity of the corresponding GAPDH bands; three mice per group were analyzed. Enzymatic activity of TRAP in protein extracts from WT and transgenic mice with a CA-AhR (B). Values are given in mean ± SD. *p < 0.05. Females: WT, n ¼ 8, and CA-AhR, n ¼ 10, and males: WT, n ¼ 8, and CA-AhR, n ¼ 7.
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Stereological Analysis of Bone and Osteoclast Volume
Density Serum analysis of CTX and TRAP 5b revealed that the resorptive activity of the osteoclast was increased, while the number of osteoclasts was unchanged. Moreover, protein expression of mature cathepsin K was increased. In order to quantify the volume density of trabecular osteoclasts, sections from tibia were stained for cathepsin K, a marker for mature and active osteoclasts (Fig. 5A) . The relative osteoclast volume density per tissue volume (Oc.V/TV) was increased by 44% in the metaphysis of female transgenic mice. This increase was also apparent when the osteoclast volume density was related to bone volume (Oc.V/BV). Oc.V/BV was increased by almost 65% in female transgenic mice, while no difference was seen in male CA-AhR mice. The bone volume correlated with tissue volume (BV/TV) was, however, unchanged (Fig. 5B) .
DISCUSSION
Many persistent environmental pollutants such as dioxins are endocrine disrupting compounds with a potential to cause different effects in males and females. In this study, we examined the bone phenotype in a transgenic mouse with a CA-AhR, which mimics continuous low-dose exposure to AhR ligands, such as dioxins. The mice were studied at the age of 3 months to ensure sexual maturity. Additional studies will be needed to assess if the bone phenotype observed in these young females is sustained in older mice. However, the transgenic mice have a reduced life span due to stomach tumors .
The results in the present study showed geometrical and qualitative alterations both in trabecular and in cortical bone tissue as well as altered expression of bone cell genes in transgenic mice. The effects were much more pronounced in female CA-AhR-mice, while very subtle or no effects were detected in male transgenic mice. The expression and activity of the transgenic receptor, estimated by CYP1A1 induction, were equivalent in bone tissue of both genders; therefore, unequal activity of the receptor cannot account for the genderrelated differences observed in this study.
In the metaphyseal part of bones from female CA-AhR mice, the trabecular area and the trabecular BMC were increased. This might indicate slow endocortical erosion that lowers the volumetric cortical BMD at the inner surface and so it falls below the threshold value for cortical bone and falls into the range for trabecular bone. Thus, an increase in trabecular area and content might be recorded even though there is increased TRANSGENIC MICE WITH CA-AHR DISPLAY A GENDER-SPECIFIC BONE PHENOTYPE 55 resorption (Gasser, 2003) . Furthermore, the osteoclast volume in the metaphysis of female CA-AhR mice was increased, and the serum levels of CTX and protein levels of cathepsin K were increased. Together, these results suggest that the trabecular bone resorption is augmented in female transgenic mice. Since the serum level of TRAP 5b was unchanged, indicating normal number of osteoclasts, it is likely that the size of the osteoclasts was increased. Osteoclast size is positively correlated with the volume of the resorption pit (Piper et al., 1992) . Also, larger osteoclasts resorb bone more efficiently, and a greater proportion of the larger osteoclasts are involved in the resorption process compared to smaller osteoclasts (Lees and Heersche, 1999; Lees et al., 2001) . The resorption index further supports this notion since the mean osteoclast activity is increased in female transgenic mice. Trabecular bone loss has been observed in female rats exposed to TCDD (Jämsa et al., 2001) . The trabecular bone volume in female Long-Evans rats exposed to 17 lg TCDD/kg was reduced by 32%, while a less dioxin-sensitive strain with a deviant AhR (Han/Wistar) was unaffected.
In the cortical part of bones from female transgenic mice, the CSA as well as the periosteal and endosteal circumference were increased, reflecting a wider diameter of the bones. However, the cortical thickness was normal. In contrast, two other studies showed that TCDD exposure (1.7 and 1 lg/kg) decreased the CSA and periosteal and endosteal circumference in femur and tibiae from female rats. However, in the same studies, other rat strains were unaffected by TCDD exposure (Jämsa et al., 2001; Miettinen et al., 2005) . The difference in response might be due to differences in experimental design, such as species, dose level, duration of exposure, and sexual maturation of the animals. The volumetric cortical BMD and total BMD were decreased in female CA-AhR mice, indicating a loss of bone tissue in the cortical part of tibia. Reduced volumetric cortical BMD has also been observed in tibia and femur of female rats exposed to 1 lg/kg TCDD (Miettinen et al., 2005) . Also, the mechanical test implies alterations in the cortical part of tibia in transgenic female mice. The displacement was increased, while the stiffness to failure and maximal stiffness was decreased, indicating less brittle bones. Female rats exposed to TCDD also exhibited decreased stiffness and reduced breaking force (Jämsa et al., 2001; Miettinen et al., 2005) . This softening of the bones might be due to an impaired mineralization process as suggested by the reduced expression of the functional osteoblast genes collagen type I and osteocalcin as well as decreased ALP activity in protein homogenate from bones of female CA-AhR mice. Also, the gene expression of DMP-1 was decreased in female CA-AhR mice. DMP-1 depletion in mice is associated with decreased bone mineralization and a disturbed phosphate homeostasis (Feng et al., 2006; Ling et al., 2005) . Mice exposed to TCDD via lactation had an increased amount of unmineralized osteoid in the tibial metaphysis and a reduced amount of mineralized bone in the tibia (Nishimura et al., 2009) . There was also a reduction of mineralized bone in the diaphysis of these mice. Male rats exposed to a single dose of 50 lg TCDD/kg were shown to have an altered mineral composition, with a shift of mineral crystal content characteristic of older bones, after only 5-day exposure (Lind et al., 2009) .
Gene expression analysis of osteoclast-associated genes showed that the early osteoclast markers are normal in female CA-AhR, suggesting that the early steps of differentiation are normal. The ratio between RANKL/OPG is increased, which in turn suggests that there is an increased drive toward osteoclast differentiation. However, when looking at the functional genes of the osteoclasts, the expression of several genes was decreased in female CA-AhR. An elevated osteoclast differentiation, suggested by the increased ratio of RANKL/OPG, together with an augmented resorption might lead to an effort to slow down the activity of the mature osteoclasts. Hence, the reduced expression of functional genes such as cathepsin K, TRAP, and MMP-9 might be part of a negative feedback mechanism. However, the mechanisms involved here should be addressed in further studies in, e.g., bone cell cultures. The osteoblast-associated genes were affected in a similar pattern in female transgenic mice. The early osteoblast markers, except Runx2, were expressed at a normal level, while the functional markers, such as collagen type I and osteocalcin, had a decreased expression, suggesting a decreased activity of the bone-forming osteoblasts. Runx2 is one of the key transcription factors in osteoblast differentiation; thus, it is possible that the altered Runx2 expression is responsible for the reduced transcription of the later functional genes. Other studies have shown that the differentiation of osteoblasts is inhibited by dioxins and AhR ligands (Gierthy et al., 1994; Korkalainen et al., 2009; Naruse et al., 2002; Nishimura et al., 2009; Ryan et al., 2007; Singh et al., 2000) , and Runx2 might be one of the key factors in AhR-perturbed osteoblastogenesis. The protein level of ALP in bone homogenate was decreased in female transgenic mice, further implying decreased bone formation in transgenic female mice. On the contrary, the serum level of PINP was elevated in female transgenic mice, which then might suggest an increased bone formation. However, PINP is a fragment of the propeptide of collagen type I, which is not entirely bone specific and might thus reflect other disturbances in the transgenic mice. Also, PINP and ALP represent different aspects of the bone formation process, i.e., type I collagen synthesis and matrix mineralization, respectively, and based on previous studies (Gierthy et al., 1994; Korkalainen et al., 2009; Naruse et al., 2002; Ryan et al., 2007; Singh et al., 2000) , TCDD seems to exert a stronger impact on the later stages of osteoblast differentiation. Taken together, bone formation is most likely decreased in the female transgenic mice.
Since loss of estrogen leads to increased bone remodeling with resorption being more pronounced than formation, antiestrogenic action of the transgenic receptor might explain the observations in female mice. These gender-specific effects are in accordance with previous reports where TCDD have been shown to have both antiestrogenic and estrogenic effects. One hypothesis is that the effect of dioxin on estrogen function is dependent on endogenous estrogen status. In ovariectomized mice, where estrogen is practically absent, TCDD induced an estrogenic response in the uterine gene expression (Boverhof et al., 2006) . However, in presence of estrogen, AhR agonists are well known to display antiestrogenic effects (Safe et al., 1998) . Also, bone has been studied with regard to presence or absence of estrogen. The dioxin-like AhR ligand PCB 126 displayed weak estrogenic activity in bone tissue in estrogen-deprived rats, but when estrogen was present, PCB 126 displayed antiestrogenic activity (Lind et al., 1999) .
In this study, we observe substantial effects in female mice with an active AhR, while very subtle or no effects occurred in male CA-AhR mice. Interestingly, epidemiological studies have indicated a comparable pattern. Swedish fishermens' wives with a higher intake of persistent organochlorine compounds had an increased fracture incidence and increased risk of vertebral fractures than those with a lower intake of persistent organochlorine compounds, while no significant effects were detected in the fishermen themselves (Alveblom et al., 2003; Wallin et al., 2004) .
In summary, a low continuous activation of the AhR results in a general bone loss in both trabecular and cortical bone tissue in female transgenic mice, while male transgenic mice almost seem to be unaffected. The loss of bone tissue in female mice is likely an effect on both bone formation and bone resorption. Our results suggest an interaction between the AhR and a female-specific mechanism involved in inhibition of osteoclast development and function.
